Resources

In order to inform safe supply recommendations, we aimed to identify why people currently smoke opioids and assess the preferred mode of consumption if people who use opioids were provided with opi

Complex gendered dynamics, including power differentials, violence, and social norms, shape the overdose crisis and drug treatment programs which can adversely impact women's experiences.

This study aims to investigate the perspectives of young who used substances to understand their motivations for access, both stated and unexpressed, to addiction services.

We sought to synthesize qualitative studies of social-structural factors influencing incidence and treatment of injecting-related infections.

In the Canadian province of Alberta, the Protection of Children Using Drugs (PChAD) act allows parents to apply for involuntary stabilization of their children for up to 15 days.

England has been slow to implement HAT.

To describe mortality due to opioid toxicity among people who experienced incarceration in Ontario between 2015 and 2020, during the fentanyl-dominant era.

The MySafe program provides pharmaceutical-grade opioids to participants with opioid use disorder via a biometric dispensing machine.

This study examined stigma experiences and the degree to which substance use treatment reduced stigma among people with SUDs who were receiving care in an outpatient treatment facility after releas

This qualitative study investigated strategies of within-group categorization and differentiation among PWUD and the roles these social categories may play in shaping intragroup attitudes, percepti

Program changes implemented in response to COVID-19 hold promise as ongoing strategies to improve MOUD treatment.

This study aimed to identify barriers and facilitators to implementing naloxone and a supervised injection facility (SIF) to reduce opioid drug-related deaths in the Republic of Ireland (ROI) and N

There is limited research linking decedents’ receipt of controlled substances and presence of controlled substances on post-mortem toxicology (PMT).

We aimed to assess the uptake of slow-release oral morphine (SROM) as second-line OAT among medically ill, hospitalised patients who declined buprenorphine and methadone.